STOCK TITAN

The Deal’s 2023 Annual Ranking Shows Abacus Life (ABL) Leads Life Settlement Industry with 26% Market Share in Funds Paid to Clients

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Abacus Life (NASDAQ: ABL) announced that it led the life settlement industry in 2023 with a 26% market share in funds paid to clients, according to The Deal's annual ranking.

The company paid $220 million in life settlement funds, equivalent to over 20% of policy face value on average, which is 32% higher than its closest competitor.

Additionally, Abacus acquired 640 policies with a collective face value of nearly $1.1 billion, reflecting a 31.4% increase from 2022, compared to the industry growth of 4%.

CEO Jay Jackson expressed pride in the company's achievements and commitment to delivering exceptional value to clients.

Positive
  • Abacus Life led the life settlement industry with a 26% market share in funds paid to clients in 2023.
  • The company paid $220 million in life settlement funds, representing over 20% of policy face value on average.
  • Abacus's payout was nearly 32% higher than its closest competitor.
  • The company acquired 640 policies with a collective face value of nearly $1.1 billion in 2023.
  • This marks a 31.4% increase in policies purchased from 2022, compared to the industry growth of 4%.
Negative
  • No significant negative business or financial aspects are reported in the press release.

Insights

Abacus Life's announcement that it led the life settlement industry by paying $220 million to clients in 2023 provides significant insights into the company's financial health and market position. Abacus’ 26% market share is an impressive feat, especially given that it delivered an average of over 20% of the policy face value to sellers, a figure 32% higher than its nearest competitor. This suggests operational efficiency and a strong capability to attract and satisfy clients.

From a financial perspective, the 31.4% increase in policies purchased from 2022 is remarkable, particularly in an industry with an annual total growth of only 4%. This growth indicates aggressive market penetration and a likely increase in revenue streams. Investors should consider the potential for sustained high growth rates but also be cautious of the scaling challenges and the economic environment's impact on the company's future performance.

The company’s ability to pay a substantial portion of the policy face value means it likely has robust actuarial models and risk assessment frameworks. However, investors should also bear in mind the sensitivity of this industry to policyholder lifespans and market conditions, which can significantly impact returns.

The data from The Deal’s annual ranking underscores Abacus Life's strong position within the life settlement market. Holding a 26% market share in funds paid to clients is a clear indicator of the company's competitive advantage. For a retail investor, this suggests that Abacus is not only a market leader but also a trusted entity in a niche financial market.

A significant aspect is the company's acquisition of 640 policies, with a collective face value nearing $1.1 billion. This marks an impressive shift from 2022 and positions Abacus as a key player likely to influence industry trends. Such growth can attract new clients, enhancing the company's market penetration. However, potential investors should assess the sustainability of this growth, as industry dynamics can shift, particularly if competitors adapt or new regulatory changes occur.

Abacus Life's performance in 2023, as highlighted by The Deal, showcases its expertise in actuarial science and risk management. The company's ability to pay out $220 million while maintaining a 26% market share indicates effective actuarial assessments and a deep understanding of longevity risk.

The fact that Abacus paid clients over 20% of policy face value on average is notable, especially given that this figure is 32% higher than the closest competitor. This suggests that Abacus's models are highly accurate, allowing them to offer better terms than their competitors while still maintaining profitability. For investors, this level of actuarial proficiency suggests a lower risk profile for their investments, provided the company continues to manage longevity risks effectively.

However, the industry is inherently linked to the unpredictability of policyholder lifespans and broader economic conditions. Significant deviations from projected mortality rates could impact payouts and profitability, which is something potential investors should monitor closely.

ORLANDO, Fla., June 06, 2024 (GLOBE NEWSWIRE) --  Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today that it led the life settlement industry in funds paid to clients in 2023 with a 26% market share according to The Deal, once again bringing premier value to its clients.

For 2023, the Company paid clients $220 million in life settlement funds, corresponding to a 26% market share and equating to paying over 20% of policy face value to sellers on average, nearly 32% higher than its closest competitor.

Additionally, the Company acquired 640 policies in 2023 with a collective face value of nearly $1.1 billion, marking an impressive 31.4% increase in policies purchased from 2022, and well ahead of annual total industry growth of 4%.

“We are thrilled to be able to place $220 million directly into our clients’ hands, once again providing incredible value to our clients,” said Abacus Chief Executive Officer Jay Jackson. “Our substantial growth in policy acquisitions further reflects the unwavering trust and confidence that policyholders have placed in Abacus. We are proud to be recognized by The Deal as the leader in funds paid to clients, and we remain committed to providing our clients with exceptional service and delivering them outstanding returns.”

About Abacus

Abacus is a leading vertically integrated alternative asset manager and market maker, specializing in longevity and actuarial technology. The company is democratizing the life insurance space through three groundbreaking new channels: ABL Tech, ABL Wealth, and ABL Longevity Growth & Income Funds. Since 2004, Abacus has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $5BN in face value of policies purchased, we have helped thousands of clients maximize the value of life insurance. Abacus Life is the only public life settlement company, trading on the Nasdaq Exchange under the ticker symbol ABL.

Over the past 20 years, the company has built an institutionalized origination and portfolio management process that is supported by a 100+ person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.

www.Abacuslife.com

Forward-Looking Statements

All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus’s financial and operational outlook; Abacus’s operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus’s ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “expect,”‎ “intend,” “anticipate,” “goals,” “prospects,” “will,” “would,” “will continue,” “will likely result,” and similar expressions (including the negative versions of such words or expressions).

While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the ‎fact that Abacus’s loss reserves are bases on estimates and may be inadequate to cover ‎its actual losses; the failure to properly price Abacus’s insurance policies; the ‎geographic concentration of Abacus’s business; the cyclical nature of Abacus’s industry; the ‎impact of regulation on Abacus’s business; the effects of competition on Abacus’s business; the failure of ‎Abacus’s relationships with independent agencies; the failure to meet Abacus’s investment ‎objectives; the inability to raise capital on favorable terms or at all; the ‎effects of acts of terrorism; and the effectiveness of Abacus’s control environment, including the identification of control deficiencies.

These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with ‎the U.S. Securities and Exchange Commission from time to time, including the Annual ‎Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent ‎periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the ‎forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations.

Contact

Abacus Life Investor Relations
investors@abacuslife.com

Abacus Life Public Relations
press@abacuslife.com


FAQ

What was Abacus Life's market share in life settlement funds paid to clients in 2023?

Abacus Life held a 26% market share in life settlement funds paid to clients in 2023.

How much did Abacus Life pay in life settlement funds in 2023?

Abacus Life paid $220 million in life settlement funds in 2023.

What was the average percentage of policy face value paid by Abacus Life in 2023?

Abacus Life paid over 20% of policy face value on average in 2023.

How did Abacus Life's payout compare to its closest competitor in 2023?

Abacus Life's payout was nearly 32% higher than its closest competitor in 2023.

How many policies did Abacus Life acquire in 2023?

Abacus Life acquired 640 policies in 2023.

What was the collective face value of the policies acquired by Abacus Life in 2023?

The collective face value of the policies acquired by Abacus Life in 2023 was nearly $1.1 billion.

What was the percentage increase in policies purchased by Abacus Life from 2022 to 2023?

There was a 31.4% increase in policies purchased by Abacus Life from 2022 to 2023.

What was the annual total industry growth in policy acquisitions in 2023?

The annual total industry growth in policy acquisitions in 2023 was 4%.

Abacus Life, Inc.

NASDAQ:ABL

ABL Rankings

ABL Latest News

ABL Stock Data

613.86M
74.68M
82.88%
17.39%
0.9%
Insurance - Life
Investment Advice
Link
United States of America
ORLANDO